Insurances.net
insurances.net » Cancer Insurance » Aarkstore Enterprise-molecular Diagnostics In Cancer Testing
Auto Insurance Life Insurance Health Insurance Family Insurance Travel Insurance Mortgage Insurance Accident Insurance Buying Insurance Housing Insurance Personal Insurance Medical Insurance Property Insurance Pregnant Insurance Internet Insurance Mobile Insurance Pet Insurance Employee Insurance Dental Insurance Liability Insurance Baby Insurance Children Insurance Boat Insurance Cancer Insurance Insurance Quotes Others
]

Aarkstore Enterprise-molecular Diagnostics In Cancer Testing

Table of Contents :

1. Overview 6

1.1 Statement of Report 6

1.2 About This Report 6

1.3 Scope of the Report 7

1.4 Objectives 7

1.5 Methodology 8

1.6 Executive Summary 9

2. Introduction to Molecular Diagnostics 13

2.1 Opening Up of Opportunities in Molecular Diagnostics 13

2.2 Impact of the Human Genome Project on Molecular Diagnostics 15

2.3 Considerations for Molecular and Clinical Diagnostics 16

2.4 Molecular Diagnostics in the Post-Genomic Era 19

2.5 Advances in Molecular Diagnostics Technologies 20

2.6 Oligonucleotide Array Platforms 21

2.7 Emerging Cancer Personalized Medicine Market 22

2.8 Companion Tests for Drug Development 24

3. Cancer Diagnostics Molecular Testing Market 27

3.1 Market Description 30

3.1.1 Market Overview 30

3.1.2 Tumor Markers 31

3.1.3 Molecular Diagnostic Markers 39

3.1.4 Competitive Landscape 40

3.1.5 Sales and Marketing Strategies for Cancer Tests 42

3.1.5.1 North American Market 44

3.1.5.2 International Markets 45

3.1.5.3 Europe 45

3.1.5.4 Asia/Pacific 46

4. Molecular Diagnostic Tests for Cancer 47

4.1 Cancer Diagnostic Tests 47

4.1.1 Use of Genomics to Understand Cancer 48

4.1.2 Molecular Diagnostic Tools Solutions 50

4.1.3 Technology of Gene Expression Analysis 51

4.1.3.1 Amplify and Detect Diminished Amounts of RNA Consistently 51

4.1.3.2 Analyze Hundreds of Genes 52

4.1.3.3 Employ Advanced Information Technology 52

4.2 Breast Cancer 53

4.2.1 Cancer Prognostic Assays 54

4.2.1.1 Oncotype DX 56

4.2.2 Single Gene Reporting (ER, PR, HER2) 57

4.2.2.1 Node Positive (N+) 57

4.2.2.2 Aromatase Inhibitors 57

4.2.3 Product Development 58

4.2.3.1 Product Development Opportunities in Breast Cancer 58

4.2.4 InterGenetics, Incorporated 58

4.2.5 HER-2 59

4.2.6 BioTheronostics (AviaraDx) 62

4.2.7 Agendia B.V. 63

4.2.8 Exagen 65

4.2.9 Applied Genomics 65

For more information please contact :

http://www.aarkstore.com/reports/Molecular-Diagnostics-in-Cancer-Testing-36109.html

http://blogs.aarkstore.com/

From:Aarkstore Enterprise

Contact: Neel

Email: press@aarkstore.com

http://www.aarkstore.com

by: Aarkstore Enterprise
$600,000 Settlement After Doctor Did Not Inform Patient Tests Showed Chance Of Prostate Cancer $2.5 Million Settlement After Doctors Delay Diagnosis Of Patient's Prostate Cancer $2.5 Million Claim For Colon Cancer Death Of 27 Year Old After Physician Dismissed Her Complaints $12,000,000 Jury Verdict For Patient After Physicians Misdiagnosed Her Breast Cancer $1.0 M Settlement Over Delayed Detection Of Prostate Cancer Side Effects Of Cervical Cancer Vaccine Cervical Cancer Symptoms Bleeding Before You Set Out For India For Treatments For Heart Failure Treatments For Relief From Kidney Stones How To Know Whether Your Skin Moles Are Cancerous: New Treatments For Heel Spurs Jesse Livermore:world Famous Day Trader The Best Approach To The Cancer Healing
Write post print
www.insurances.net guest:  register | login | search IP(34.229.110.49) / Processed in 0.012494 second(s), 5 queries , Gzip enabled debug code: 114 , 2591, 301,
Aarkstore Enterprise-molecular Diagnostics In Cancer Testing